You just read:

Italian Medicines Agency (AIFA) Approves the Reimbursement of Zebinix® (eslicarbazepine acetate) as an Adjunctive Treatment to be Administered Once Daily in the Treatment of Partial Epilepsy in Adults

News provided by

Eisai Europe Limited

12 May, 2014, 00:01 BST